The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study.
Simonsen MR, Haunstrup LM, Severinsen FT, Jensen RK, Brown PN, Maurer MJ, Khurana A, Jensen P, Jørgensen JM, Stauffer Larsen T, Clausen MR, Poulsen CB, Dessau-Arp A, El-Galaly TC, Jakobsen LH.
Simonsen MR, et al. Among authors: haunstrup lm.
Leuk Lymphoma. 2024 Dec;65(14):2173-2181. doi: 10.1080/10428194.2024.2390561. Epub 2024 Sep 3.
Leuk Lymphoma. 2024.
PMID: 39225407
Free article.